ALK and anaplastic large cell lymphoma: After induction chemotherapy, high risk selected patients with ALK-negative ALCL may benefit from high dose therapy with BEAM (carmustine, etoposide, doxorubicin, melphalan) conditioning followed by autologous stem cell transplant in first remission [14].